Butterfly (BFLY) Q3 2026 Earnings Call Transcript

Butterfly Network reported Q3 2026 revenue of $32.6 million, up 52% year over year and 9% above the top end of guidance; adjusted gross margin reached a company-record 73.0%, and adjusted EBITDA loss narrowed 85% to $1.2 million. The company raised FY2026 revenue guidance to $123 million–$126 million and improved adjusted EBITDA loss guidance to $12 million–$15 million, while maintaining its target for positive adjusted EBITDA and cash flow by 2028. Embedded revenue rose more than 1,000% to $11.1 million, though international revenue fell 5% to $5.1 million; management also established a $150 million ATM program, describing it as proactive and saying there is no immediate need for cash.

Analysis

The key quality question is whether growth is broadening beyond Embedded, not whether the headline growth rate persists. Core POCUS growth is modest, while Embedded—development, licensing and chip-related work—can be milestone-driven and partner-concentrated; it should not yet be valued as a recurring royalty stream. Enterprise contract TCV also is not equivalent to near-term recognized revenue: deployments can take time, with probe sales and software revenue layering in gradually. Compass AI’s ability to manage rival systems could open doors at hospitals, but hardware pull-through remains a separate execution test. The reported margin step-up is not a clean run rate: mix helped, and a tariff refund is nonrecurring. Watch underlying gross margin excluding both effects.

Near term, the raised annual outlook and reduced cash use support sentiment, but the Q4 range implies variability rather than a straight-line acceleration. The 2027 catalysts—international enterprise execution, federal wins, P5.1 launch and partner commercialization—are progressively less verifiable and should not be capitalized as delivered earnings. The $150 million ATM is optional, not proof of imminent funding need; however, it creates meaningful potential dilution if management uses strength to finance the roadmap. Cash-flow breakeven in 2028 remains a company target, not an established trajectory.

Contrarian view: software interoperability and the partner ecosystem may create strategic value beyond probe sales, but investors may be conflating pipeline, contract value and commercial royalties. No valuation or share-price data are provided, so the quarter alone cannot establish upside or a price target.

Key Decisions for Investors

• Do not chase a post-earnings spike on headline growth. Consider a small, staged BFLY long only after checking valuation and liquidity; add only if 2027 guidance and subsequent results show Core POCUS growth alongside Embedded, rather than milestone revenue alone.
• For the next 1–3 months, monitor Q4 Embedded revenue versus the prior-year comparison, Core revenue/unit trends, and gross margin excluding the tariff refund and mix effects. A slowdown in Core or a sharp normalized-margin reversal would weaken the thesis.
• Treat enterprise TCV and the Embedded pipeline as leading indicators, not booked recurring revenue. Seek evidence of Compass software renewals/expansion, implementation cadence and partner commercialization before underwriting a durable multiple premium.
• Track ATM usage in SEC filings and dilution against cash use and R&D needs. Repeated issuance without measurable revenue or cash-flow progress would be a thesis negative; material federal wins or independently evidenced partner royalties would be positive catalysts.